$5.03
-0.0400 (-0.789%)
At Close: Jul 31, 2026
Senseonics Holdings, Inc. (SENS) Q4 2025 Earnings Call Transcript
08:27pm, Monday, 02'nd Mar 2026
Senseonics Holdings, Inc. (SENS) Q4 2025 Earnings Call Transcript
Senseonics Holdings (SENS) Reports Q4 Loss, Tops Revenue Estimates
06:11pm, Monday, 02'nd Mar 2026
Senseonics Holdings (SENS) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to a loss of $0.4 per share a year ago.
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
04:01pm, Monday, 02'nd Mar 2026
Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration,
SENS Eversense 365 Integrated With twiist Gains Full Availability
08:16am, Friday, 20'th Feb 2026
Senseonics rolls out Eversense 365 integrated with Sequel's twiist AID system, aiming to boost CGM adoption with its year-long wear advantage.
Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365
08:00am, Thursday, 19'th Feb 2026
The integrated system is now being used in real-world care settings and is widely available for people with type 1 diabetes The integrated system is now being used in real-world care settings and is w
Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365
08:00am, Thursday, 19'th Feb 2026
The integrated system is now being used in real-world care settings and is widely available for people with type 1 diabetes The integrated system is now being used in real-world care settings and is w
Senseonics Holdings, Inc. (NYSE:SENS) Receives Average Rating of “Buy” from Brokerages
02:08am, Wednesday, 18'th Feb 2026
Shares of Senseonics Holdings, Inc. (NYSE: SENS - Get Free Report) have been assigned a consensus rating of "Buy" from the six ratings firms that are presently covering the stock, MarketBeat Ratings r
All You Need to Know About Senseonics (SENS) Rating Upgrade to Buy
01:02pm, Friday, 06'th Feb 2026
Senseonics (SENS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Senseonics (SENS) Moves 5.3% Higher: Will This Strength Last?
08:05am, Monday, 02'nd Feb 2026
Senseonics (SENS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
SENS Stock Up as Eversense 365 CGM Wins European CE Mark Approval
01:10pm, Friday, 30'th Jan 2026
Senseonics stock jumps after Eversense 365 wins CE Mark, expanding Europe access for its one-year CGM and strengthening the long-term growth outlook.
Senseonics Receives European Approval for Eversense 365, World's Longest-lasting Continuous Glucose Monitor
04:01pm, Thursday, 29'th Jan 2026
GERMANTOWN, Md., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuo
SENS Stock Up as Eversense 365 Enters AID Market With twiist System
11:55am, Friday, 09'th Jan 2026
Senseonics shares gain after Eversense 365 became the first one-year implantable CGM integrated with an automated insulin delivery system.
twiist™ becomes the first AID system compatible with Senseonics Eversense® 365 one-year CGM twiist™ becomes the first AID system compatible with Senseonics Eversense® 365 one-year CGM
Senseonics Holdings, Inc. (NYSE:SENS) Receives Average Rating of “Buy” from Analysts
03:18am, Tuesday, 30'th Dec 2025
Senseonics Holdings, Inc. (NYSE: SENS - Get Free Report) has been given an average recommendation of "Buy" by the six analysts that are covering the company, MarketBeat.com reports. One equities resea
HBK Sorce Advisory LLC Acquires New Stake in Senseonics Holdings, Inc. $SENS
05:24am, Sunday, 28'th Dec 2025
HBK Sorce Advisory LLC bought a new position in shares of Senseonics Holdings, Inc. (NYSE: SENS) during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC.
Sign In
Buy SENS